Healthcare · Pharmaceuticals & Biotechnology
No company profile on record yet.
| Fiscal year | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Total income (before exceptional items) | 474† | 442† | 315† | — | 395† |
| Net profit | 64† | — | -19† | -58† | 30† |
₹ Crore. † Summed from the four quarterly filings of that fiscal year.
Current board roster from exchange filings. Director remuneration is not in our data, so it isn't shown.
| Name | Designation | Term end |
|---|---|---|
| ANUPAMA DATLA DESAI | Executive Director | March 31, 2026 |
| KRISHNA VASANTKUMAR DATLA | Executive Director | March 31, 2026 |
| PRASHANT PRABHAKAR NAGRE | Executive Director | March 31, 2026 |
| SATISH VARMA AZAD NADIMPALLY | Executive Director | March 31, 2026 |
| PRADEEP M CHANDAN | Independent Director | March 31, 2026 |
| PRAMOD KASAT | Independent Director | March 31, 2026 |
| RAJASHRI OJHA | Independent Director | March 31, 2026 |
| RAMANAND MUNDKUR | Independent Director | March 31, 2026 |
| RAJESHWARI DATLA | Non-Executive Director | March 31, 2026 |
Key management names, their remuneration, subsidiaries and brand listings are not in the exchange filings we ingest yet, so they are not shown here rather than estimated.
